Poland· PL-100438199
Uldiulan
A chlortalidone product containing chlortalidonum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Chlortalidone is registered in 11 of 19 countries.
Countries holding a registration under ATC C03BA04 (chlortalidone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Chlortalidone · ATC C03BA04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of chlortalidone costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.40 in Switzerland to $5.90 in United States — a ×15 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Chlortalidone · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- US United States$5.90 (acquisition cost)
- CH Switzerland$0.40
The record
At a glance
URPL (Poland)- Active substance
- Chlortalidonum
- Manufacturer
- G.L. Pharma GmbH
- Country
- Poland (PL)
- ATC code
- C03BA04
- ATC class
- Chlortalidone
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin09008732016079
- gtin09008732016086
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
264 interactions on record for chlortalidone.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Chlortalidone · interactions on record
264 records
- 4 severe
- 208 moderate
- 19 minor
- 29 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Aminolevulinic acidL01XD04severe
- Arsenic trioxideL01XX27severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Chlortalidone in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesChlorthalidoneBryant Ranch Prepack
- United KingdomChlortalidone 50mg tabletsCST Pharma Ltd
- CzechiaULDIULANG.L. Pharma GmbH, Lannach
- SpainCLORTALIDONA GLENMARK 50 MG COMPRIMIDOS EFGGlenmark Arzneimittel Gmbh
- CanadaAPO-CHLORTHALIDONEAPOTEX INC
- NetherlandsChloortalidon Glenmark 50 mg tablettenGlenmark Arzneimittel GmbH
- SwitzerlandChlortalidon Galepharm
- BelgiumAtenolol/Chloortalidone EG 100 mg - 25 mgEG
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Hydrosan, Uldiulan
- Belgium · Hygroton
- Bulgaria · Zornichka, Зорничка
- Czechia · Uldiulan
- Germany · Chlortalidon Axiromed, Chlortalidon Glenmark
- Spain · Clortalidona Glenmark, Higrotona
- United Kingdom (Northern Ireland) · Chlortalidone Glenmark Pharmaceuticals Europe, Chlortalidone Morningside Healthcare
- Greece · Hygroton, Unidone
- Croatia · Kataldi, Klortalidon Sandoz
- Hungary · Uldiulan
- Italy · Igroton
- Netherlands · Chloortalidon Focus Care, Chloortalidon Glenmark
- Portugal · Clorotalidona Farmoz, Clorotalidona Glenmark
- Romania · Uldiulan
- Sweden · Hygropax
- Slovakia · Uldiulan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f0f7796c-cd2a-4ff9-9618-7921ea9f4d08 GET /v1/drugs/f0f7796c-cd2a-4ff9-9618-7921ea9f4d08?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "50 mg",
"packaging": "09008732016079 ¦ Rp ¦ 147957\n50 tabl.\n09008732016086 ¦ Rp ¦ 147958\n100 tabl.",
"substance": "Chlortalidonum 50 mg",
"common_name": "Chlortalidonum",
"pl_product_id": "100438199",
"pozwolenie_nr": "27509",
"auth_procedure": "DCP",
"authorisation_validity": "2027-11-25"
}See everything about chlortalidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.